http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0347148-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-09
filingDate 1990-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc73a53703b5cdb6582ae13ea7614f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c770f8fe49600c6a4da6a0e813be59
publicationDate 1991-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0347148-A
titleOfInvention Production of isocarbacyclins
abstract PURPOSE: To produce isocarbacyclins, prostaglandin I 2 relative, industrially and advantageously by reacting a 4,4'-bisarylsulfonylisocarbacyclin with a reducing agent. n CONSTITUTION: A 4,4'-bisarylsulfonylisocarbacyclin (enantiomer or mixture in an arbitrary ratio) shown by formula I (R 1 is alkyl or alkenyl; R 2 and R 3 are trihydrocarbon silyl or group with O of OH to form acetal group; R 4 is H, methyl or vinyl; R 5 is alkyl, alkenyl or alkynyl which may contain O, phenyl, phenoxy, cycloalkyl, etc.; Ar is phenyl) is reacted with a reducing agent and optionally subjected to deprotecting reaction and/or hydrolysis to give an isocarbacyclin shown by formula II (R 11 are H, alkyl or alkenyl; R 21 and R 31 are H, trihydrocarbon silyl, etc.). n COPYRIGHT: (C)1991,JPO&Japio
priorityDate 1990-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6377839-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226870908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070562

Total number of triples: 32.